$APOG

Apogee Enterprises Inc (APOG) (Q2 2027) Earnings Call Highlights: Raised Guidance

Apogee Enterprises (APOG) reported Q2 2027 revenue of $391M, up 9% YoY, and adjusted EPS of $1.17, up 19%. The company raised its fiscal 2027 outlook due to strong first-half performance. Segment performance varied, with Services growing for the 10th consecutive quarter, while Glass and Performance Surfaces faced challenges. Acquisitions of Kalwall and Groglass are progressing well. Leverage ratio is 1.7 times, slightly above target. The company repurchased $6.4M of stock in Q2.

Original reporting
Published Oct 6, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Apogee Enterprises Inc (APOG) (Q2 2027) Earnings Call Highlights: Raised Guidance — source image
Decision brief

The 30-second read

$APOGBullishMed
01

Why it matters

The earnings beat and guidance lift provide fresh, material information that can affect short‑term price action and sector sentiment.

02

Market read

Guidance raise after a solid quarter is likely to drive buying interest in APOG and may influence related industrial stocks.

03

What to watch

Higher leverage (1.7x) and material cost pressures could constrain cash flow if growth slows.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Apogee Enterprises (NASDAQ:APOG) is a mid‑cap industrial company with segments in services, metals, glass, and performance surfaces.

Company-level read

Ticker impact

$APOGBullishMedium confidence
Context

Apogee Enterprises raised its FY2027 net sales guidance to $1.46‑$1.5 B and adjusted EPS to $3‑$3.40 after reporting Q2 revenue of $391 M and EPS $1.17.

Expected impact

likely upward as investors price in higher sales and earnings expectations

Evidence & confidence

The company delivered better‑than‑expected Q2 results and lifted guidance, a fresh primary disclosure that typically moves the stock positively.

Market effects

Positive for industrial manufacturing and specialty glass/metal segments as Apogee's growth may signal demand recovery.

U.S. industrial sector may see modest uplift.

Limited to investors tracking mid‑cap industrials.

Counterpoint

If the raised guidance is already priced in, the stock could face a short‑term pull‑back.

Key entities

  • Apogee Enterprises Inc

    Subject of the earnings call and guidance raise.

  • Kalwall

    Acquisition contributing to revenue growth.

  • Groglass

    Expected to add $30 M revenue and 25% EBITDA margin.

Related articles

$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

$APOGHighAI 8/10

Apogee (APOG) Q2 2027 Earnings Call Transcript

Apogee (APOG) reported Q2 2027 earnings with net sales up 9.2% to $391.1M, driven by acquisitions and pricing. Adjusted EBITDA margin rose to 12.7%, and EPS increased 19% to $1.17. The company highlighted progress in metals, services, and glass segments, with services delivering 10 consecutive quarters of growth. Acquisitions of Kalwall and GrowGlass are expected to enhance capabilities and profitability. Management expressed confidence in long-term growth and shareholder value creation.

$APOGHighAI 8/10

Apogee raises fiscal 2027 guidance after second-quarter sales rise

Apogee Enterprises (APOG) reported a 9.2% sales increase to $391.1M in Q2, raising its fiscal 2027 adjusted EPS guidance to $3.00-$3.40 and net sales outlook to $1.46B-$1.50B. Operating income rose 24.5% to $33.5M, while net earnings fell 5.4% to $22.4M. Growth was driven by acquisitions, pricing, and product mix, though offset by lower volume and higher costs.

$APOGMed

Apogee Enterprises Q2 Earnings Call Highlights

Apogee Enterprises reported Q2 sales growth in all segments, with Architectural Metals up 1.8%, Services up 8%, Glass up 21%, and Performance Surfaces up 14%. Adjusted EBITDA margins varied, with Glass improving sequentially. The company expects Kalwall and Groglass acquisitions to boost revenue but have a modest EPS impact in 2027. Apogee repurchased $6.4M in stock and paid $5.5M in dividends, maintaining a leverage ratio of 1.7x.

$CEGHighAI 8/10

Market movers: Constellation Energy, Marvell, Lamb Weston, Option Care

Diodes (DIOD) received a buy rating and $135 target from BofA, expecting 58% annual EPS growth. Apogee (APOG) raised fiscal 2027 guidance after Q2 sales rose 9.2%. Marvell (MRVL) shares rose 6.5% on $70B-$90B 2031 revenue forecast. Lamb Weston (LW) increased 2027 targets despite net income drop. SAP (SAP) to acquire TechWolf; Mckesson (MCK) & CD&R to buy Option Care Health (OPCH) for $5.8B. Constellation Energy (CEG) in 20-year PPA with Alphabet (GOOG).